IDT Australia Limited
ASX:IDT.AX
Overview | Financials
Company Name | IDT Australia Limited |
Symbol | IDT.AX |
Currency | AUD |
Price | 0.12 |
Market Cap | 47,572,452 |
Dividend Yield | 0% |
52-week-range | 0.05 - 0.145 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Paul McDonald |
Website | https://en.idtaus.com.au |
An error occurred while fetching data.
About IDT Australia Limited
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services. The company also provides project management, chemical, analytical chemistry, pharmacy,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD